Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 7, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Camptothecin: Potential Cancer Treatment Found In Assam

DAIKENCHUTO: A JAPANESE HERBAL MEDICATION METHOD

Zoonotic illness: Transmission between man and animal

Camptothecin: Potential Cancer Treatment Found In Assam
  • BiotechToday
  • World

Camptothecin: Potential Cancer Treatment Found In Assam

bioxone March 24, 2021March 24, 2021

Thota Kanishka Rao, Amity University Kolkata

Cancer is the second leading cause of death worldwide and is responsible for causing nearly 10 million deaths per annum. The significant reason cancer being so lethal is due to the absence of anti-cancer treatments. Though, very recently researchers have discovered a new plant species having the potential to aid in fighting cancer.

The species named Ophiorrhiza recurvipetala has been discovered in the central district of Assam and classified under the Rubiaceae family of flowering plants, to which the plant yielding coffee belongs. All the members of this group consist of a secondary metabolite known as Camptothecin utilized in colon cancer.

Ophiorrhiza is a primarily herbaceous class found from eastern India toward the West Pacific from South China to northern Australia. As per the World Checklist of Selected Plant Families, 2017, it is a remarkably species-rich and systematically convoluted sort with around 318 species around the world. 

In India, 47 species and 9 varieties have been found. The Ophiorrhiza recurvipetala is an enduring spice with a height of 60 cm and is branched. It yields a creamy white flower.

Researchers have reported that these species are restricted to growing in moist and shady places only. It would require more scientific study and experimentation to see if the Camptothecin content occurring in this novel species would be useful to treat cancer or not.

Also read:DAIKENCHUTO: A JAPANESE HERBAL MEDICATION METHOD

Source: https://www.thehindu.com/news/national/new-assam-plant-species-may-aid-anti-cancer-battle/article34103961.ece

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Related

Tagged anti-cancer Assam Camptothecin cancer Ophiorrhiza recurvipetala Rubiaceae family treatment

One thought on “Camptothecin: Potential Cancer Treatment Found In Assam”

  1. Pingback: Zoonotic illness: Transmission between man and animal - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Zoonotic illness: Transmission between man and animal

bioxone March 25, 2021

Rohit Bhattacharjee, Amity University, Kolkata Zoonotic illnesses are those contaminations that can pass between species from animals to mankind, just as from mankind to animals. Most (60.3 percent) arising infections influencing people had an animal source and most of these (71.8 percent) came from natural life, as per a recent report.  While COVID-19’s unique leap […]

Zoonotic

Related Post

  • BiotechToday
  • World

Targeting viral protein ORF3a to fight Covid-19!

BioTech Today June 27, 2021June 27, 2021

Monika R, PSG College of Technology, Coimbatore The novel severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) has caused a global pandemic of COVID-19 on an unprecedented scale. Coronaviruses may cause acute and chronic respiratory, enteric, and CNS infections. The presence of a large number of asymptomatic/mildly symptomatic patients, effective human-to-human transmission, and immunomodulatory characteristics of SARS-CoV-2 contribute […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

USEFULNESS OF CGX-1321 IN OVARIAN CANCER TREATMENT

bioxone November 17, 2020November 16, 2020

Biswadeep Sen, Amity University Kolkata Ovarian Cancer is one of the most notorious forms of cancers, causing pain and discomfort to 1 in 108 women worldwide. Immune checkpoint therapy has shown that the presence of Immune Phenotypes limits its efficacy against this deadly foe. The previous digging had shed light upon the Wnt/β-catenin pathway and […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

Longer gap between vaccine doses: Effective or not?

BioTech Today July 8, 2021July 7, 2021

Anjali Kumari, IILM College of Engineering and Technology Longer gap (up to 45 weeks) between the Covid-19 vaccines may increase the immune response. According to a new study from the University of Oxford in the United Kingdom, it has been stated that a gap of up to 45 weeks between the first and second doses […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy